Market Research Report
Cell Expansion - Global Market Outlook (2017-2023)
|Published by||Stratistics Market Research Consulting||Product code||599917|
|Published||Content info||168 Pages
Delivery time: 2-3 business days
|Cell Expansion - Global Market Outlook (2017-2023)|
|Published: December 1, 2017||Content info: 168 Pages||
According to Stratistics MRC, the Global Cell Expansion market is expected to grow from $8.57 billion in 2016 to reach $28.30 billion by 2023 with a CAGR of 18.6%. Rising high prevalence of chronic diseases, increasing government funding for research, soaring company investments for the development of cell-based products and technological advancements in cell expansion techniques are the major factors driving the market growth. However, high cost of operation required for cell expansion techniques and ethical concerns hamper the growth of the market.
By product, cell expansion supporting equipment segment is divided into flow cytometer, centrifuges, cell counter, and other supporting equipment. Cell expansion technology has emerged as a promising therapeutic solution for brain and spinal cord injuries, neurodegeneration, cardiovascular disorders, blood cell formation, diabetes, and a myriad of other conditions. It is also used to diagnose some types of tumors, and used in the production of regenerative medicines.
Geographically, North America dominates the cell expansion market owing to the rapid growth in the number of patients suffering from chronic diseases the market is expected to witness huge growth in this region.
Some of the key players in the Cell Expansion market include GE Healthcare, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, Miltenyi Biotec, STRYKER CORP, Merck KGAA, MEDTRONICS'S PLC, Corning, Inc, Terumo BCT Inc, Beckman Coulter Inc, Sigma-Aldrich Corporation, Stemcell Technologies and Lonza Group Ltd.
End Users Covered:
Cell Types Covered:
What our report offers: